Science 37
About Science 37
Science 37 is a modern clinical research site that delivers trials directly to patients’ homes. This approach aims to make clinical research accessible to anyone, anywhere, regardless of their proximity to traditional research sites. The company leverages a Direct-to-Patient Site model with nationwide reach and medical licensure across all 50 states, enabling sponsors to expand access, improve retention, and enroll more representative patient populations compared to traditional site-based methods.
With over a decade of experience, Science 37 has supported more than 200 clinical trials across various phases and observational studies. Their model has demonstrated strong performance, including high completion rates and significant contributions to total study enrollment, validated by the Tufts Center for the Study of Drug Development (Tufts CSDD).
Focus Areas
Business Intelligence
| Technology | Network Oriented Research Assistant (NORA) platform, Science 37 Operating System (OS), cloud-native, AI-powered patient matching and screening, EHR integration, patient relationship management, contact center technology |
What Physicians Need to Know
Science 37 offers physicians the opportunity to participate in clinical research regardless of their proximity to traditional research sites, leveraging board-certified physicians with multi-state medical licensure. Their model allows for broader patient access and diversity in trials, potentially leading to more representative study populations and faster trial timelines. The use of research-grade nurses for in-home visits ensures high-quality data collection and patient care. Their FDA-inspected direct-to-patient site status provides assurance of regulatory compliance and data integrity.
The official website text mentions a partnership with PatientsLikeMe to unlock trial access for interested, eligible patients. It also lists several partners including Acer Therapeutics, Adrenas, Advarra, Anthos Therapeutics, Avillion, Bayer, Biohaven, Boehringer Ingelheim, Catalent, Chugai Pharmaceutical, Delfi, Escient Pharmaceuticals, GSK, Harmony Biosciences, Jazz Pharmaceuticals, LabConnect, Mirum Pharmaceuticals, PureTech Health, and RxE2. No specific technology integrations are detailed beyond these partnerships.
Videos
News, demos, and interviews about Science 37.
Videos load interactively. If none appear, search YouTube for Science 37 →
Frequently Asked Questions
Investors
Who's funded Science 37.
Related Companies
Pear Therapeutics was a pioneer in the field of prescription digital therapeutics (PDTs), developing software-based treatments for various disorders. The company aimed to integrate clinically-validated software applications with traditional treatment paradigms to improve patient outcomes, provide clinicians with smarter engagement and tracking tools, and offer cost-effective solutions for payers. These products were designed to deliver […]
LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]
Viv Health provides an AI-powered intelligent assistant specifically designed for women’s health and OB/Gyn clinicians. This AI automates routine administrative tasks such as patient intake, triage, message management, visit preparation, and follow-ups. By handling these time-consuming activities, Viv aims to free up clinicians to concentrate on direct patient care. The system uses conversational AI to […]
Value Health AI is a healthcare AI company that aims to drive smarter healthcare decisions through AI-first solutions. They focus on turning fragmented healthcare data into clear, actionable insights to enable better patient outcomes and operational excellence. Their philosophy is “AI-Led. Human-Assured,” combining AI innovation with human expertise to accelerate workflows, uncover insights, and automate […]

